# Emerging Technologies: Current State

## Overview

Emerging technologies are advancing rapidly across multiple domains, with regulatory frameworks struggling to keep pace and significant governance gaps creating both opportunities and risks.

## Quantum Computing

### Development Status

| Metric | Status |
|--------|--------|
| Qubit counts | 1,000+ (IBM, Google) |
| Error correction | Active research |
| Practical applications | Limited, growing |
| Quantum advantage | Demonstrated for specific problems |

### Key Players

| Sector | Players |
|--------|---------|
| US companies | IBM, Google, Microsoft, IonQ |
| US government | DOE, NIST, NSA |
| China | National programs, Alibaba |
| Europe | Various national programs |

### Policy Issues

| Issue | Status |
|-------|--------|
| Cryptographic transition | NIST post-quantum standards |
| Export controls | Limited |
| National investment | CHIPS and Science Act |
| Workforce | Shortage |

## Biotechnology

### Gene Editing (CRISPR)

| Application | Status |
|-------------|--------|
| Therapeutic | First approvals (sickle cell) |
| Agricultural | Widespread |
| Germline (human) | Restricted, some violations |
| Gene drives | Research stage |

### Synthetic Biology

| Application | Status |
|-------------|--------|
| Industrial | Growing |
| Agricultural | Emerging |
| Medical | Research, some products |
| Biosecurity | Concern |

### Governance

| Area | Status |
|------|--------|
| FDA oversight | Therapeutic approvals |
| USDA | Agricultural |
| EPA | Environmental |
| NIH guidelines | Research protocols |
| International | Biosafety Protocol |

## Autonomous Systems

### Current Deployment

| System | Status |
|--------|--------|
| Autonomous vehicles | Testing, limited deployment |
| Drones | Widespread, regulated |
| Industrial robots | Common |
| Autonomous weapons | Research, controversy |
| Agricultural | Growing |

### Regulatory Landscape

| Area | Status |
|------|--------|
| Vehicles | NHTSA, state rules |
| Drones | FAA Part 107 |
| Weapons | DoD policy, international debate |
| Industrial | OSHA, limited |
| Liability | Unclear |

## Brain-Computer Interfaces

### Development

| Application | Status |
|-------------|--------|
| Medical (invasive) | Clinical trials, FDA approvals |
| Medical (non-invasive) | Commercial products |
| Consumer | Limited products |
| Research | Active |

### Key Players

| Actor | Focus |
|-------|-------|
| Neuralink | Invasive consumer |
| Synchron | Medical |
| BrainGate | Medical research |
| Academic | Various |

### Governance

| Issue | Status |
|-------|--------|
| FDA medical device | Existing framework |
| Consumer devices | Gap |
| Data/privacy | Limited |
| Ethics | Guidelines only |

## Advanced Materials and Nanotechnology

### Applications

| Area | Status |
|------|--------|
| Electronics | Widespread |
| Medicine | Growing |
| Materials | Commercial |
| Energy | Emerging |

### Governance

| Issue | Status |
|-------|--------|
| EPA authority | Limited TSCA |
| FDA | Product-specific |
| OSHA | Workplace exposure |
| International | Voluntary guidelines |

## Space Technologies

### Current Landscape

| Area | Status |
|------|--------|
| Commercial launch | Active (SpaceX, others) |
| Satellites | Proliferating |
| Space tourism | Beginning |
| Asteroid mining | Future |
| Debris | Growing problem |

### Governance

| Area | Status |
|------|--------|
| Outer Space Treaty | 1967 framework |
| FAA licensing | Launch/reentry |
| FCC | Spectrum |
| International | Limited coordination |
| Debris mitigation | Voluntary guidelines |

## Extended Reality (XR)

### Development

| Technology | Status |
|------------|--------|
| VR headsets | Consumer available |
| AR glasses | Limited, growing |
| Metaverse platforms | Multiple |
| Enterprise use | Growing |

### Governance Issues

| Issue | Status |
|-------|--------|
| Privacy | Limited regulation |
| Safety | No standards |
| Content moderation | Platform policies |
| Children | Concerns, limited rules |
| Interoperability | None required |

## Nuclear Fusion

### Development Status

| Project | Status |
|---------|--------|
| NIF | Ignition achieved (2022) |
| ITER | Construction |
| Private ventures | Multiple funded |
| Timeline | Still decades away |

### Policy Issues

| Issue | Status |
|-------|--------|
| NRC authority | Unclear for fusion |
| International cooperation | ITER framework |
| Investment | Growing |
| Grid integration | Future planning |

## Cross-Cutting Issues

### Dual Use

| Technology | Dual Use Concern |
|------------|------------------|
| AI | Weapons, surveillance |
| Biotech | Pathogens, enhancement |
| Quantum | Cryptography breaking |
| Drones | Civilian, military |
| Space | Civilian, military |

### Convergence

| Convergence | Examples |
|-------------|----------|
| AI + Biotech | Drug discovery, biosecurity |
| Quantum + AI | Optimization, machine learning |
| Neurotech + AI | Brain interfaces |
| Nano + Bio | Targeted medicine |

### International Competition

| Area | US Position |
|------|-------------|
| AI | Leading but challenged |
| Quantum | Competitive |
| Biotech | Leading |
| Space | Maintaining lead |
| Semiconductors | Challenged |

---

## Document Navigation

- Previous: [Overview](01-overview.md)
- Next: [History](03-history.md)
